Deka Bank Deutsche Girozentrale Heron Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$16.93 - $26.22 $660,270 - $1.02 Million	-39,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$23.15 - $28.34 $902,850 - $1.11 Million	39,000 New	39,000 $1.51 Million
Q4 2018 Feb 12, 2019	SELL	$22.03 - $32.01 $859,170 - $1.25 Million	-39,000 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$30.0 - $40.85 $30,000 - $40,850	-1,000 Reduced 2.5%	39,000 $0
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $1.06 Million - $1.68 Million	40,000 New	40,000 $1.64 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.